| abstract |
The present invention relates to a composition for preventing or treating obesity comprising a pupae, and more specifically, a pharmaceutical composition for preventing or treating obesity, including Honeybee Drone Pupas as an active ingredient, for preventing or improving obesity It relates to a method for preventing or treating obesity, comprising administering a food composition and a quasi-drug composition to an individual. The pupae according to the present invention has a lipase activity, an adipocyte proliferation inhibitory effect, a fat tissue weight increase inhibitory effect, an adipogenesis-related gene expression inhibitory effect, an obesity inhibitory pathway activation effect, etc., so that obesity can be prevented, improved or treated. It can be used in various ways in the field of obesity improvement, where continuous growth is predicted, as it can be used in the manufacture of pharmaceuticals and functional foods. |